The transformative potential of AI-driven CRISPR-Cas9 genome editing to enhance CAR T-cell therapy

被引：2
|
作者：
机构：
[1] Boretti, Alberto
来源：
| 1600年 / Elsevier Ltd卷 / 182期
关键词：
Gene therapy;
D O I：
10.1016/j.compbiomed.2024.109137
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Exploring the potential of genome editing CRISPR-Cas9 technology
    Singh, Vijai
    Braddick, Darren
    Dhar, Pawan Kumar
    GENE, 2017, 599 : 1 - 18
  • [2] CRISPR-Cas9 Genome Editing and Rapid Selection of Cell Pools
    Stoyko, Daniel
    Timothy, O.
    Hernandez, Adrianna
    Konstantinidou, Parthena
    Meng, Qingcai
    Haase, Astrid D.
    CURRENT PROTOCOLS, 2022, 2 (12):
  • [3] Development and Applications of CRISPR-Cas9 for Genome Editing
    Zhang, Feng
    HUMAN GENE THERAPY, 2014, 25 (11) : A10 - A10
  • [4] The Implications of CRISPR-Cas9 Genome Editing for IR
    Perkons, Nicholas R.
    Sheth, Rahul
    Ackerman, Daniel
    Chen, James
    Saleh, Kamiel
    Hunt, Stephen J.
    Nadolski, Gregory J.
    Shi, Junwei
    Gade, Terence P.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (09) : 1264 - 1267
  • [5] CRISPR-Cas9 Mediated Genome Editing in Drosophila
    Peng, Ping
    Wang, Xia
    Shen, Da
    Sun, Jin
    Jia, Yu
    Xu, Rong-Gang
    Zhu, Li-Fei
    Ni, Jian-Quan
    BIO-PROTOCOL, 2019, 9 (02):
  • [6] CRISPR-Cas9 Genome Editing of Plasmodium knowlesi
    Mohring, Franziska
    Hart, Melissa N.
    Patel, Avnish
    Baker, David A.
    Moon, Robert W.
    BIO-PROTOCOL, 2020, 10 (04):
  • [7] Photoactivatable CRISPR-Cas9 for optogenetic genome editing
    Nihongaki, Yuta
    Kawano, Fuun
    Nakajima, Takahiro
    Sato, Moritoshi
    NATURE BIOTECHNOLOGY, 2015, 33 (07) : 755 - 760
  • [8] Therapeutic potential of CRISPR/Cas9 gene editing in engineered T-cell therapy
    Gao, Qianqian
    Dong, Xuan
    Xu, Qumiao
    Zhu, Linnan
    Wang, Fei
    Hou, Yong
    Chao, Cheng-chi
    CANCER MEDICINE, 2019, 8 (09): : 4254 - 4264
  • [9] Inducible in vivo genome editing with CRISPR-Cas9
    Lukas E Dow
    Jonathan Fisher
    Kevin P O'Rourke
    Ashlesha Muley
    Edward R Kastenhuber
    Geulah Livshits
    Darjus F Tschaharganeh
    Nicholas D Socci
    Scott W Lowe
    Nature Biotechnology, 2015, 33 : 390 - 394
  • [10] Inducible in vivo genome editing with CRISPR-Cas9
    Dow, Lukas E.
    Fisher, Jonathan
    O'Rourke, Kevin P.
    Muley, Ashlesha
    Kastenhuber, Edward R.
    Livshits, Geulah
    Tschaharganeh, Darjus F.
    Socci, Nicholas D.
    Lowe, Scott W.
    NATURE BIOTECHNOLOGY, 2015, 33 (04) : 390 - U98
12345